Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Melanoma | Research

Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study

Authors: Nadia C. W. Kamminga, Marlies Wakkee, Rianne J. De Bruin, Astrid. A. M. van der Veldt, Arjen Joosse, Suzan W. I. Reeder, Peter W. Plaisier, Tamar Nijsten, Marjolein Lugtenberg

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

The increasing group of melanoma survivors reports multiple unmet needs regarding survivorship care (SSC). To optimise melanoma SSC, it is crucial to take into account the perspectives of oncological healthcare providers (HCPs) in addition to those of patients. The aim of this study is to gain an in-depth understanding of HCPs’ perspectives on appropriate melanoma SSC.

Methods

Four online focus groups were conducted with mixed samples of oncological HCPs (dermatologists, surgeons, oncologists, oncological nurse practitioners, support counsellors and general practitioners) (total n = 23). A topic guide was used to structure the discussions, focusing on perspectives on both SSC and survivorship care plans (SCPs). All focus groups were recorded, transcribed verbatim, and subjected to an elaborate thematic content analysis.

Results

Regarding SSC, HCPs considered the current offer minimal and stressed the need for broader personalised SSC from diagnosis onwards. Although hardly anyone was familiar with SCPs, they perceived various potential benefits of SCPs, such as an increase in the patients’ self-management and providing HCPs with an up-to-date overview of the patient’s situation. Perceived preconditions for successful implementation included adequate personalisation, integration in the electronic health record and ensuring adequate funding to activate and provide timely updates.

Conclusions

According to HCPs there is considerable room for improvement in terms of melanoma SSC. SCPs can assist in offering personalised and broader i.e., including psychosocial SSC. Aside from personalisation, efforts should be focused on SCPs' integration in clinical practice, and their long-term maintenance.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed
2.
go back to reference Leeneman B, Schreuder K, Uyl-de Groot CA, van Akkooi ACJ, Haanen J, Wakkee M, et al. Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003–2018): A nationwide population-based study. Eur J Cancer. 2021;154:111–9.CrossRefPubMed Leeneman B, Schreuder K, Uyl-de Groot CA, van Akkooi ACJ, Haanen J, Wakkee M, et al. Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003–2018): A nationwide population-based study. Eur J Cancer. 2021;154:111–9.CrossRefPubMed
3.
go back to reference Wolchok JD, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Lao CD, et al. Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma. J Clin Oncol. 2022;40(2):127–37.CrossRefPubMed Wolchok JD, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Lao CD, et al. Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma. J Clin Oncol. 2022;40(2):127–37.CrossRefPubMed
4.
go back to reference Weiss SA, Kluger H. CheckMate-067: Raising the Bar for the Next Decade in Oncology. J Clin Oncol. 2022;40(2):111–3.CrossRefPubMed Weiss SA, Kluger H. CheckMate-067: Raising the Bar for the Next Decade in Oncology. J Clin Oncol. 2022;40(2):111–3.CrossRefPubMed
5.
go back to reference Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, et al. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472–92.CrossRefPubMedPubMedCentral Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, et al. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472–92.CrossRefPubMedPubMedCentral
6.
go back to reference Kamminga NCW, van der Veldt AAM, Joosen MCW, de Joode K, Joosse A, Grunhagen DJ, et al. Experiences of resuming life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma. Br J Dermatol. 2022;187(3):381–91. Kamminga NCW, van der Veldt AAM, Joosen MCW, de Joode K, Joosse A, Grunhagen DJ, et al. Experiences of resuming life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma. Br J Dermatol. 2022;187(3):381–91.
7.
go back to reference Husson O, Holterhues C, Mols F, Nijsten T, van de Poll-Franse LV. Melanoma survivors are dissatisfied with perceived information about their diagnosis, treatment and follow-up care. Br J Dermatol. 2010;163(4):879–81.CrossRefPubMed Husson O, Holterhues C, Mols F, Nijsten T, van de Poll-Franse LV. Melanoma survivors are dissatisfied with perceived information about their diagnosis, treatment and follow-up care. Br J Dermatol. 2010;163(4):879–81.CrossRefPubMed
8.
go back to reference Hewitt M, Greenfield S, Stovall E. Lost in transition. From cancer patient to cancer survivor. National Academies Press, 2005:1–506. Hewitt M, Greenfield S, Stovall E. Lost in transition. From cancer patient to cancer survivor. National Academies Press, 2005:1–506.
9.
go back to reference Netherlands Health Council of the Netherlands. Follow-up in Oncology. Identify objectives, substantiate actions. The Hague: Health Council of the Netherlands, 2007; publication no. 2007/10. Netherlands Health Council of the Netherlands. Follow-up in Oncology. Identify objectives, substantiate actions. The Hague: Health Council of the Netherlands, 2007; publication no. 2007/10.
10.
go back to reference President’s Cancer Panel. Living Beyond Cancer: Finding a New Balance: Bethesda, MD: National Cancer Institute; 2004. President’s Cancer Panel. Living Beyond Cancer: Finding a New Balance: Bethesda, MD: National Cancer Institute; 2004.
11.
go back to reference Nederlandse Melanoomwerkgroep. Landelijke Richtlijn Melanoom. IKNL, 2019. Nederlandse Melanoomwerkgroep. Landelijke Richtlijn Melanoom. IKNL, 2019.
12.
go back to reference Hill RE, Wakefield CE, Cohn RJ, Fardell JE, Brierley ME, Kothe E, et al. Survivorship Care Plans in Cancer: A Meta-Analysis and Systematic Review of Care Plan Outcomes. Oncologist. 2020;25(2):e351–72.CrossRefPubMed Hill RE, Wakefield CE, Cohn RJ, Fardell JE, Brierley ME, Kothe E, et al. Survivorship Care Plans in Cancer: A Meta-Analysis and Systematic Review of Care Plan Outcomes. Oncologist. 2020;25(2):e351–72.CrossRefPubMed
13.
go back to reference Mayer DK, Birken SA, Check DK, Chen RC. Summing it up: an integrative review of studies of cancer survivorship care plans (2006–2013). Cancer. 2015;121(7):978–96.CrossRefPubMed Mayer DK, Birken SA, Check DK, Chen RC. Summing it up: an integrative review of studies of cancer survivorship care plans (2006–2013). Cancer. 2015;121(7):978–96.CrossRefPubMed
14.
go back to reference Jabson JM, Bowen DJ. Cancer treatment summaries and follow-up care instructions: which cancer survivors receive them? Cancer Causes Control. 2013;24(5):861–71.CrossRefPubMed Jabson JM, Bowen DJ. Cancer treatment summaries and follow-up care instructions: which cancer survivors receive them? Cancer Causes Control. 2013;24(5):861–71.CrossRefPubMed
15.
go back to reference de Rooij BH, Ezendam NP, Nicolaije KA, Vos MC, Pijnenborg JM, Boll D, et al. Factors influencing implementation of a survivorship care plan-a quantitative process evaluation of the ROGY Care trial. J Cancer Surviv. 2017;11(1):64–73.CrossRefPubMed de Rooij BH, Ezendam NP, Nicolaije KA, Vos MC, Pijnenborg JM, Boll D, et al. Factors influencing implementation of a survivorship care plan-a quantitative process evaluation of the ROGY Care trial. J Cancer Surviv. 2017;11(1):64–73.CrossRefPubMed
16.
go back to reference Green J, Thorogood N. Qualitative methodology in health research. Qualitative methods for health research. Fourth edition. London: SAGE Publications Ltd.; 2018. Green J, Thorogood N. Qualitative methodology in health research. Qualitative methods for health research. Fourth edition. London: SAGE Publications Ltd.; 2018.
18.
go back to reference Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.CrossRefPubMed Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.CrossRefPubMed
20.
22.
go back to reference Bloor M, Wood F. Keywords in Qualitative Methods: Purposive sampling. Qualitative evaluation and research methods (2nd ed). Newbury Park, CA: SAGE Publications; 2016. Bloor M, Wood F. Keywords in Qualitative Methods: Purposive sampling. Qualitative evaluation and research methods (2nd ed). Newbury Park, CA: SAGE Publications; 2016.
23.
go back to reference Hennink MM, Kaiser BN, Marconi VC. Code Saturation Versus Meaning Saturation: How Many Interviews Are Enough? Qual Health Res. 2017;27(4):591–608.CrossRefPubMed Hennink MM, Kaiser BN, Marconi VC. Code Saturation Versus Meaning Saturation: How Many Interviews Are Enough? Qual Health Res. 2017;27(4):591–608.CrossRefPubMed
24.
go back to reference Dunn J, Watson M, Aitken JF, Hyde MK. Systematic review of psychosocial outcomes for patients with advanced melanoma. Psychooncology. 2017;26(11):1722–31.CrossRefPubMed Dunn J, Watson M, Aitken JF, Hyde MK. Systematic review of psychosocial outcomes for patients with advanced melanoma. Psychooncology. 2017;26(11):1722–31.CrossRefPubMed
25.
go back to reference Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef
26.
go back to reference Dierckx de Casterle B, Gastmans C, Bryon E, Denier Y. QUAGOL: a guide for qualitative data analysis. Int J Nurs Stud. 2012;49(3):360–71.CrossRefPubMed Dierckx de Casterle B, Gastmans C, Bryon E, Denier Y. QUAGOL: a guide for qualitative data analysis. Int J Nurs Stud. 2012;49(3):360–71.CrossRefPubMed
27.
go back to reference Berry L, Seiders K, Wilder S. Innovations in access to care: a patient-centered approach. Ann Intern Med. 2003;139(7):569–74.CrossRef Berry L, Seiders K, Wilder S. Innovations in access to care: a patient-centered approach. Ann Intern Med. 2003;139(7):569–74.CrossRef
28.
go back to reference Moran J, Bekker H, Latchford G. Everyday use of patient-centred, motivational techniques in routine consultations between doctors and patients with diabetes. Patient Educ Couns. 2008;73(2):224–31.CrossRefPubMed Moran J, Bekker H, Latchford G. Everyday use of patient-centred, motivational techniques in routine consultations between doctors and patients with diabetes. Patient Educ Couns. 2008;73(2):224–31.CrossRefPubMed
29.
go back to reference de Rooij BH, Ezendam NPM, Vos MC, Pijnenborg JMA, Boll D, Kruitwagen R, et al. Patients’ information coping styles influence the benefit of a survivorship care plan in the ROGY Care Trial: New insights for tailored delivery. Cancer. 2019;125(5):788–97.CrossRefPubMed de Rooij BH, Ezendam NPM, Vos MC, Pijnenborg JMA, Boll D, Kruitwagen R, et al. Patients’ information coping styles influence the benefit of a survivorship care plan in the ROGY Care Trial: New insights for tailored delivery. Cancer. 2019;125(5):788–97.CrossRefPubMed
30.
go back to reference Bennett AE, O'Neill L, Connolly D, Guinan E, Boland L, Doyle S, et al. Perspectives of Esophageal Cancer Survivors on Diagnosis, Treatment, and Recovery. Cancers (Basel). 2020;13(1). Bennett AE, O'Neill L, Connolly D, Guinan E, Boland L, Doyle S, et al. Perspectives of Esophageal Cancer Survivors on Diagnosis, Treatment, and Recovery. Cancers (Basel). 2020;13(1).
31.
go back to reference de Wind A, Tamminga SJ, Bony CAG, Diether M, Ludwig M, Velthuis MJ, et al. Loss of Paid Employment up to 4 Years after Colorectal Cancer Diagnosis-A Nationwide Register-Based Study with a Population-Based Reference Group. Cancers (Basel). 2021;13(12). de Wind A, Tamminga SJ, Bony CAG, Diether M, Ludwig M, Velthuis MJ, et al. Loss of Paid Employment up to 4 Years after Colorectal Cancer Diagnosis-A Nationwide Register-Based Study with a Population-Based Reference Group. Cancers (Basel). 2021;13(12).
32.
go back to reference Gunn KM, Olver I, Skrabal Ross X, Harrison N, Livingston PM, Wilson C. Improving Survivors' Quality of Life Post-Treatment: The Perspectives of Rural Australian Cancer Survivors and Their Carers. Cancers (Basel). 2021;13(7). Gunn KM, Olver I, Skrabal Ross X, Harrison N, Livingston PM, Wilson C. Improving Survivors' Quality of Life Post-Treatment: The Perspectives of Rural Australian Cancer Survivors and Their Carers. Cancers (Basel). 2021;13(7).
33.
go back to reference Roodbeen RTJ, Lugtenberg M, Postges H, Lansink KWW, Theeuwes HP, de Jongh MAC, et al. Experiences of recovery and posthospital care needs of working-age adults after physical trauma: a qualitative focus group study. BMJ Open. 2022;12(4): e053330.CrossRefPubMedPubMedCentral Roodbeen RTJ, Lugtenberg M, Postges H, Lansink KWW, Theeuwes HP, de Jongh MAC, et al. Experiences of recovery and posthospital care needs of working-age adults after physical trauma: a qualitative focus group study. BMJ Open. 2022;12(4): e053330.CrossRefPubMedPubMedCentral
34.
go back to reference Keesing S, McNamara B, Rosenwax L. Cancer survivors’ experiences of using survivorship care plans: a systematic review of qualitative studies. J Cancer Surviv. 2015;9(2):260–8.CrossRefPubMed Keesing S, McNamara B, Rosenwax L. Cancer survivors’ experiences of using survivorship care plans: a systematic review of qualitative studies. J Cancer Surviv. 2015;9(2):260–8.CrossRefPubMed
35.
go back to reference Klemanski DL, Browning KK, Kue J. Survivorship care plan preferences of cancer survivors and health care providers: a systematic review and quality appraisal of the evidence. J Cancer Surviv. 2016;10(1):71–86.CrossRefPubMed Klemanski DL, Browning KK, Kue J. Survivorship care plan preferences of cancer survivors and health care providers: a systematic review and quality appraisal of the evidence. J Cancer Surviv. 2016;10(1):71–86.CrossRefPubMed
36.
go back to reference Rea S, Pathak J, Savova G, Oniki TA, Westberg L, Beebe CE, et al. Building a robust, scalable and standards-driven infrastructure for secondary use of EHR data: the SHARPn project. J Biomed Inform. 2012;45(4):763–71.CrossRefPubMedPubMedCentral Rea S, Pathak J, Savova G, Oniki TA, Westberg L, Beebe CE, et al. Building a robust, scalable and standards-driven infrastructure for secondary use of EHR data: the SHARPn project. J Biomed Inform. 2012;45(4):763–71.CrossRefPubMedPubMedCentral
37.
go back to reference Peng C, Goswami P. Meaningful Integration of Data from Heterogeneous Health Services and Home Environment Based on Ontology. Sensors (Basel). 2019;19(8). Peng C, Goswami P. Meaningful Integration of Data from Heterogeneous Health Services and Home Environment Based on Ontology. Sensors (Basel). 2019;19(8).
38.
go back to reference Boer H, Nuver J, Lefrandt JD, Duijzer AW, Bunskoek S, Berendsen AJ, et al. Easy navigating through the forest of survivorship care. J Clin Oncol. 2014;32(1):61–2.CrossRefPubMed Boer H, Nuver J, Lefrandt JD, Duijzer AW, Bunskoek S, Berendsen AJ, et al. Easy navigating through the forest of survivorship care. J Clin Oncol. 2014;32(1):61–2.CrossRefPubMed
39.
go back to reference Parry C, Kent EE, Forsythe LP, Alfano CM, Rowland JH. Can’t see the forest for the care plan: a call to revisit the context of care planning. J Clin Oncol. 2013;31(21):2651–3.CrossRefPubMedPubMedCentral Parry C, Kent EE, Forsythe LP, Alfano CM, Rowland JH. Can’t see the forest for the care plan: a call to revisit the context of care planning. J Clin Oncol. 2013;31(21):2651–3.CrossRefPubMedPubMedCentral
41.
go back to reference Anbari AB, Wanchai A, Graves R. Breast cancer survivorship in rural settings: a systematic review. Support Care Cancer. 2020;28(8):3517–31.CrossRefPubMed Anbari AB, Wanchai A, Graves R. Breast cancer survivorship in rural settings: a systematic review. Support Care Cancer. 2020;28(8):3517–31.CrossRefPubMed
43.
go back to reference Kemp E, Trigg J, Beatty L, Christensen C, Dhillon HM, Maeder A, et al. Health literacy, digital health literacy and the implementation of digital health technologies in cancer care: the need for a strategic approach. Health Promot J Austr. 2021;32(Suppl 1):104–14.CrossRefPubMed Kemp E, Trigg J, Beatty L, Christensen C, Dhillon HM, Maeder A, et al. Health literacy, digital health literacy and the implementation of digital health technologies in cancer care: the need for a strategic approach. Health Promot J Austr. 2021;32(Suppl 1):104–14.CrossRefPubMed
44.
go back to reference Deckers EA, Hoekstra-Weebers J, Damude S, Francken AB, Ter Meulen S, Bastiaannet E, et al. The MELFO Study: A Multicenter, Prospective, Randomized Clinical Trial on the Effects of a Reduced Stage-Adjusted Follow-Up Schedule on Cutaneous Melanoma IB-IIC Patients-Results After 3 Years. Ann Surg Oncol. 2020;27(5):1407–17.CrossRefPubMed Deckers EA, Hoekstra-Weebers J, Damude S, Francken AB, Ter Meulen S, Bastiaannet E, et al. The MELFO Study: A Multicenter, Prospective, Randomized Clinical Trial on the Effects of a Reduced Stage-Adjusted Follow-Up Schedule on Cutaneous Melanoma IB-IIC Patients-Results After 3 Years. Ann Surg Oncol. 2020;27(5):1407–17.CrossRefPubMed
45.
go back to reference Ke Y, Ng T, Chan A. Survivorship care models for breast cancer, colorectal cancer, and adolescent and young adult (AYA) cancer survivors: a systematic review. Support Care Cancer. 2018;26(7):2125–41.CrossRefPubMed Ke Y, Ng T, Chan A. Survivorship care models for breast cancer, colorectal cancer, and adolescent and young adult (AYA) cancer survivors: a systematic review. Support Care Cancer. 2018;26(7):2125–41.CrossRefPubMed
46.
go back to reference Konttila J, Siira H, Kyngas H, Lahtinen M, Elo S, Kaariainen M, et al. Healthcare professionals’ competence in digitalisation: A systematic review. J Clin Nurs. 2019;28(5–6):745–61.CrossRefPubMed Konttila J, Siira H, Kyngas H, Lahtinen M, Elo S, Kaariainen M, et al. Healthcare professionals’ competence in digitalisation: A systematic review. J Clin Nurs. 2019;28(5–6):745–61.CrossRefPubMed
47.
go back to reference Green J, Thorogood N. Qualitative research in a digital age. Qualittive methods for health research. Fourth edition. London: SAGE Publications Ltd; 2018. Green J, Thorogood N. Qualitative research in a digital age. Qualittive methods for health research. Fourth edition. London: SAGE Publications Ltd; 2018.
Metadata
Title
Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study
Authors
Nadia C. W. Kamminga
Marlies Wakkee
Rianne J. De Bruin
Astrid. A. M. van der Veldt
Arjen Joosse
Suzan W. I. Reeder
Peter W. Plaisier
Tamar Nijsten
Marjolein Lugtenberg
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-10759-9

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine